You can buy or sell ARMP and other stocks, options, ETFs, and crypto commission-free!
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. Read More The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.
Los Angeles, California
52 Week High
52 Week Low